Advitech Dermylex roll out begins in Canada

By staff reporter

- Last updated on GMT

Related tags: Ulcerative colitis, Advitech

Advitech's global roll out plan for its psoriasis nutraceutical
Dermylex is coming together, with definitive agreements in Canada
and France, interim financing, and new appointments as it moves
into the implementation phase.

The Quebec-based company announced a definitive agreement for the distribution of its whey-derived ingredient in Canada with Jamieson Laboratories last week, following the conclusion of a market test in pharmacies in Toronto and Quebec City.

"The market test has demonstrated the definitive interest of patients in Dermylex,"​ said Advitech president and CEO Renaud Beauchesne.

More than 6 million adults in North America suffer from psoriasis, an immune system disorder, but until now those with mild to medium forms of the condition have had to resort to topical therapies or aggressive drug treatments with significant side effects.

Beauchesne did not reveal precise sales figures, but said that the results of the market test were "above Advitech's and Jamieson's expectations"​.

The exclusive, three-year deal with Jamieson was announced around the beginning of this year; product introduction has already begun, and it being supported by promotional activities and advertising.

The confirmation for Canada came just two weeks after Advitech announced that it had finalised its deal for France with Cothera.

At that time the company said it had raised C$350,000 in interim financing to fund the on-on-going commercialisation effort, in the form of a $200,000 participative non-guaranteed loan from the Centre Québécois de Valorisation des Biotechnologies (CQVB) and convertible debentures totalling $150,000 from private investors.

It has now increased this to $550,000 with the issue of a new block of $100,000 convertible debentures with a private investor, and a $100,000 loan (refundable contribution) from a government agency earmarked for overseas commercialisation.

Deals are also in the works to take Dermylex into the US, with PhotoMedex, and Taiwan with Enbio-Life Biotechnology & Medical Co.

Christian Brouillette is also joining Advitech this week as director of sales and marketing, an appointment that coincides with the departure of VP Jean-Luc Martre, who has overseen the pre-commercialisation phase.

Beauchesne said Brouilllette's experience will "make it possible to develop the full potential of the different Dermylex commercialisation agreements and to initiate new partnerships in our target markets."

Kim Cantin also becomes quality control/assurance director - an important function in the current implementation phase. Part of her responsibility is regulatory restrictions in different markets.

The company's strategy has been to ensure there is strong scientific support behind the ingredient (initially known as XP-828L), which intended first and foremost to help alleviate mild to moderate psoriasis but which may also lead to the develop natural health products to target chronic inflammatory diseases such as Crohn's disease, ulcerative colitis and arthritis.

This was in order to build credibility with pharmacists and health professionals such as dermatologists, who may recommend the supplement to patients.

Related topics: Dairy-based ingredients

Related news

Show more

Related products

show more

Know your Ethnic Dairy Opportunities

Know your Ethnic Dairy Opportunities

DuPont Nutrition & Biosciences | 05-Dec-2018 | Technical / White Paper

Global consumers often look for something new from the yogurt category and products with a good story. In Western markets, this demand is driving a trend...

Everything about in-container sterilization

Everything about in-container sterilization

John Bean Technologies (JBT) | 01-Nov-2018 | Application Note

JBT has a long history and an extensive track record in thermal processing of packaged food. JBT retorts and sterilizers are renowned for their outstanding...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 04-Oct-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

GLOBAL PREFERENCES: TEXTURANTS PLAY A KEY ROLE.

GLOBAL PREFERENCES: TEXTURANTS PLAY A KEY ROLE.

Tate and Lyle | 16-May-2018 | Technical / White Paper

Texture is a matter of taste, and that’s true on a global scale as well. What appeals to consumers in Italy might turn off those in Indonesia. As formulators,...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars